CRISPR and Gene Editing in Neurodegenerative Diseases: Current Applications and Future Therapeutic Potential

CRISPR and Gene Editing in Neurodegenerative Diseases Current Applications and Future Therapeutic Potential   Abstract Neurodegenerative diseases continue to pose profound challenges to modern medicine, affecting millions of individuals worldwide and contributing significantly to disability, mortality, and healthcare expenditure. Disorders such as Alzheimer’s disease, Parkinson’s disease, Huntington’s disease,

Biomarkers for Alzheimer’s Disease: PET to Plasma

Biomarkers for Alzheimer’s Disease: PET to Plasma  Abstract Background:The diagnostic landscape of Alzheimer’s disease (AD) has shifted considerably in recent years. Traditional diagnosis relied heavily on clinical assessments supported by neuropsychological testing and structural imaging. These approaches, while valuable, often lacked the sensitivity and specificity needed to

Hearing Loss And Functional Decline

Hearing Loss And Functional Decline Overview Hearing loss has been recognized as one of the major modifiable risk factors for cognitive decline and dementia. However, studies exploring this connection have yielded mixed results. This study aimed to assess the long-term relationship between self-reported hearing loss and cognitive/functional abilities in 695 cognitively

Tau Accumulation And White Matter Changes Linked To Hypertension

Tau Accumulation And White Matter Changes Linked To Hypertension Overview This study explored how amyloid buildup and hypertension interact to affect tau accumulation and atrophy in the entorhinal cortex (EC), while also investigating cerebral blood flow (CBF) as a potential shared mechanism. The researchers analyzed data from two cohorts of older adults

Alzheimer’s Disease Revealed By Reliable Digital Memory Assessments

Alzheimer's Disease Revealed By Reliable Digital Memory Assessments Alzheimer's disease (AD) research has advanced in detecting pathological changes through biomarkers, but cognitive measures lag in capturing early, subtle impairments. Traditional assessments designed for overt deficits are now outpaced by discoveries in episodic memory networks within the medial temporal lobe, which are

Dementia Risk Increase In Diabetic Patients With Poor Glycemic Control

Dementia Risk Increase In Diabetic Patients With Poor Glycemic Control Overview This study investigated the association between glycemic variability and dementia risk among 171,964 individuals with type 2 diabetes. Despite optimal glycosylated hemoglobin A1c (HbA1c) levels, variability in HbA1c over the long term was found to increase the hazard of dementia. The

CRISPR and Gene Editing in Neurodegenerative Diseases: Current Applications and Future Therapeutic Potential